The safety and feasibility of using motixafortide for stem cell mobilization in people with sickle cell disease (SCD) will…
Joana Vindeirinho, PhD
Joana is a Science Writer at BioNews. She is a cell biologist with a PhD in neurobiology of disease (University of Coimbra, Portugal), focused on the role of the adenosinergic system in the early stages of diabetic retinopathy. She moved from research into high-impact medical editing in 2017, before shifting into a more direct science writing and communication role in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Joana Vindeirinho, PhD
Black women in California with sickle cell disease (SCD) have worse pregnancy outcomes than do Black women in the…